Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Christoph Hammerstingl , Added: 1 year ago
Clinical data shows that routine use of intravascular imaging improves clinical outcomes of patients undergoing PCI. It delivers critical anatomical information pre and post-stenting. Thereby, HD-IVUS enables “high-precision” interventional therapy. Intravascular imaging should become the standard of care, not just for complex PCI procedural guidance. View more
Research Area(s) / Expertise: Job title: Professor of Cardiology, Université de Mons (UMons), Mons, Belgium
Dr. Stéphane G. Carlier is a renowned interventional cardiologist at Hôpital Ambroise Paré and a Professor of Cardiology at the Université de Mons (UMons) in Mons, Belgium. He earned his M.D. from the Université Libre de Bruxelles in 1996 and his Ph.D. in Biomedical Engineering from Erasmus University in Rotterdam in 2001. Dr. Carlier previously served as an Assistant Professor of Clinical… View more
Author(s): Joost Daemen Added: 1 year ago
Clinical data shows that routine use of intravascular imaging improves clinical outcomes of patients undergoing PCI. It delivers critical anatomical information pre-and post-stenting. Thereby, HD-IVUS enables “high-precision” interventional therapy. especially for complex PCI procedural guidance. View more
Author(s): Joo-Yong Hahn Added: 1 year ago
ACC.23/WCC - Principal investigator, Dr Joo-Yong Hahn (Samsung Medical Center, KR) joins us to discuss the findings of the RENOVATE-COMPLEX-PCI late-breaking trial (Samsung Medical Center). The investigators compared clinical outcomes between intravascular imaging guided (IVUS) versus angiography guided (OCT) percutaneous coronary intervention (PCI) in 1639 patients with complex lesions … View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 9 months ago
What's hot at EuroPCR 2024?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?Trials covered included:00… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What are the take-home messages from ESC 2O23? Join us as we delve into the pivotal results that ignited debates and discussions at ESC Congress 2023. Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) return with their "View from the Thoraxcenter" review, where they analyse the hot line and late-breaking trials presented in Amsterdam. In this ESC 2023… View more
Job title: Professor of Medicine
Professor Maehara is the Director of the Intravascular Imaging Core Laboratory at the CRF Clinical Trials Center. She is also a Professor of Medicine at Columbia University College of Physicians and Surgeons in New York View more
Author(s): Annapoorna Kini Added: 1 year ago
ACC.23/WCC — Principle investigator of YELLOW III, Dr Annapoorna Subhash Kini(Mount Sinai Hospital, US) joins us to talk about the study that assessed the effect of evolocumab (Repatha) on coronary plaque morphology using intravascular imaging and gene expression analysis of peripheral blood mononuclear cells (PBMC) in 140 patients with stable CAD on maximally tolerated statin therapy … View more
Research Area(s) / Expertise:
Dr Valeria Paradies is an interventional cardiologist at Maasstad Hospital and PhD Candidate at Erasmus University Medical Center, Rotterdam, the Netherlands. Her research interests focus on pharmacotherapy and full revascularisation in ACS, stent platform safety, intravascular imaging for PCI guidance, and non-obstructive coronary artery disease. View more
Author(s): Added: 1 year ago
In this interview, Dr Masaru Seguchi (German Heart Centre, DE) explains the aim of the BIOMAG-I OCT analysis, what the findings were and what the data means for the future of cardiology. View more